CERTOLIZUMAB PEGOL IS EFFECTIVE IN UVEITIS ASSOCIATED TO SPONDYLOARTHRITIS REFRACTORY TO OTHER TUMOUR NECROSIS FACTOR INHIBITORS

被引：4

作者：

Hernandez, M. V. ^{[1
]}

Mesquida, M. ^{[2
]}

Llorens, V. ^{[2
]}

de la Maza, M. Sainz ^{[2
]}

Blanco, R. ^{[3
]}

Calvo, V. ^{[3
]}

Maiz, O. ^{[4
]}

Blanco, A. ^{[5
]}

Urruticoechea, A. ^{[6
]}

Jimenez de Aberasturi, J. R. D. D. ^{[7
]}

Ahijado, P. ^{[8
]}

Judez, E. ^{[9
]}

Tejon, P. ^{[10
]}

Pena, S. ^{[11
]}

Adan, A. ^{[2
]}

Sanmarti, R. ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Rheumatol, Barcelona, Spain

[2] Hosp Clin Barcelona, Ophtalmol, Barcelona, Spain

[3] Hosp Marques de Valdecilla, Rheumatol, Santander, Spain

[4] Hosp Univ Donostia, Rheumatol, San Sebastian, Spain

[5] Hosp Univ Donostia, Ophtalmol, San Sebastian, Spain

[6] Hosp Can Misses, Rheumatol, Ibiza, Spain

[7] Txagorritxu Hosp, Rheumatol, Vitoria, Spain

[8] Hosp Univ Infanta Elena, Rheumatol, Madrid, Spain

[9] Complejo Hosp Univ Albacete, Rheumatol, Albacete, Spain

[10] Hosp Univ Gen Castellon, Rheumatol, Castellon de La Plana, Spain

[11] Hosp Univ Gen Castellon, Ophtalmol, Castellon de La Plana, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.4425

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0381

引用

页码：350 / 350

页数：1

共 50 条

[31] Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain
Hidalgo-Vega, Alvaro
Villoro, Renata
Blasco, Juan Antonio
Talavera, Pablo
Ferro, Belen
Purcaru, Oana
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
[32] Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain
Álvaro Hidalgo-Vega
Renata Villoro
Juan Antonio Blasco
Pablo Talavera
Belén Ferro
Oana Purcaru
Cost Effectiveness and Resource Allocation, 13
[33] MULTICENTER STUDY OF TUMOUR NECROSIS FACTOR ALPHA ANTAGONISTS FOR REFRACTORY BEHCET'S UVEITIS IN SPAIN
Mesquida, M.
Hernandez, M. V.
Espinosa, G.
Diaz Valle, D.
Cordero Coma, M.
Fonollosa, A.
Llorenc, V.
Pelegrin, L.
Molins, B.
Adan, A.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 488 - 489
[34] New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol
Cauli, Alberto
Piga, Matteo
Lubrano, Ennio
Marchesoni, Antonio
Floris, Alberto
Mathieu, Alessandro
JOURNAL OF RHEUMATOLOGY, 2015, 42 : 70 - 72
[35] Mapping the Certolizumab Pegol Epitope on Tumor Necrosis Factor and Comparison With Infliximab, Adalimumab, and Etanercept
Henry, Alistair
Gong, Hai Ping
Nesbitt, Andrew N.
GASTROENTEROLOGY, 2011, 140 (05) : S630 - S630
[36] The effect of tumour necrosis factor inhibitors on radiographic progression in axial spondyloarthritis: a systematic literature review
Boers, Nadine
Michielsens, Celia A. J.
van der Heijde, Desiree
den Broeder, Alfons A.
Welsing, Paco M. J.
RHEUMATOLOGY, 2019, 58 (11) : 1907 - 1922
[37] Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis
Zhao, Sizheng Steven
Yoshida, Kazuki
Jones, Gareth T.
Hughes, David M.
Duffield, Stephen J.
Tedeschi, Sara K.
Lyu, Houchen
Moots, Robert J.
Solomon, Daniel H.
Goodson, Nicola J.
ARTHRITIS RESEARCH & THERAPY, 2019, 21
[38] Drug Survival of Tumour Necrosis Factor-α Inhibitors in Patients with Ankylosing Spondylitis and Axial Spondyloarthritis
Chu, Raymond
Chow, Andrew
Soucy, Elaine
Bhatt, Palki
Got, Tiffany
Hong, Daniel
JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1331 - 1331
[39] Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis
Sizheng Steven Zhao
Kazuki Yoshida
Gareth T. Jones
David M. Hughes
Stephen J. Duffield
Sara K. Tedeschi
Houchen Lyu
Robert J. Moots
Daniel H. Solomon
Nicola J. Goodson
Arthritis Research & Therapy, 21
[40] Effectiveness of certolizumab pegol in chronic anterior uveitis associated to Crohn's disease and ankylosing spondylitis
Maiz Alonso, Olga
Blanco Esteban, Ana Carmen
Eguees Dubuc, Cesar Antonio
Martinez Zabalegui, David
REUMATOLOGIA CLINICA, 2015, 11 (03): : 189 - 190

← 1 2 3 4 5 →